Skip to main navigation Skip to search Skip to main content

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment

  • Sushil Badrising
  • , Vincent Van Der Noort
  • , Inge M. Van Oort
  • , H. Pieter Van Den Berg
  • , Maartje Los
  • , Paul Hamberg
  • , Jules L. Coenen
  • , Alfons J.M. Van Den Eertwegh
  • , Igle J. De Jong
  • , Emile D. Kerver
  • , Harm Van Tinteren
  • , Andries M. Bergman

Research output: Contribution to journalArticlepeer-review

131 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science